meglitinide has been researched along with Fasting Hypoglycemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Frei, CR; Kennedy, KE; Patek, TM; Teng, C | 1 |
| Kopecky, C | 1 |
| Davis, SN; Lamos, EL; Stein, SA | 1 |
| Abe, J; Hara, H; Kinosada, Y; Nagasawa, H; Nakamura, M; Nishibata, Y; Suzuki, Y; Umetsu, R | 1 |
| Becker, M; Galler, A; Raile, K | 1 |
| Grulich-Henn, J; Holl, RW; Konrad, K; Meissner, T; Raile, K; Scheuing, N; Schober, E; Thon, A; Wölfle, J | 1 |
| Backman, JT; Neuvonen, PJ; Niemi, M; Tornio, A | 1 |
| Andres, E; Blicklé, JF; Brogard, JM; Neyrolles, N | 1 |
4 review(s) available for meglitinide and Fasting Hypoglycemia
| Article | Year |
|---|---|
Use of noninsulin antidiabetic medications in hospitalized patients.
Topics: Benzamides; Biguanides; Bromocriptine; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islet Amyloid Polypeptide; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2013 |
Sulfonylureas and meglitinides: historical and contemporary issues.
Topics: Animals; Benzamides; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Glyburide; History, 20th Century; History, 21st Century; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Ischemic Preconditioning; Neoplasms; Risk Assessment; Risk Factors; Sulfonylurea Compounds; Treatment Outcome; Weight Gain | 2013 |
Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications.
Topics: Administration, Oral; Aryl Hydrocarbon Hydroxylases; Benzamides; Cytochrome P-450 CYP2C8; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme Inhibitors; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Humans; Hypoglycemia; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2012 |
[Present status in the treatment of type 2 diabetes mellitus. Insulin-secreting agents].
Topics: Adenosine Triphosphate; Administration, Oral; Benzamides; Binding Sites; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Potassium Channels; Protein Binding; Sulfonylurea Compounds; Treatment Failure | 1999 |
4 other study(ies) available for meglitinide and Fasting Hypoglycemia
| Article | Year |
|---|---|
Hypoglycemia Associated with Antibiotics Alone and in Combination with Sulfonylureas and Meglitinides: An Epidemiologic Surveillance Study of the FDA Adverse Event Reporting System (FAERS).
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Benzamides; Drug Interactions; Humans; Hypoglycemia; Hypoglycemic Agents; Odds Ratio; Sulfonylurea Compounds; United States; United States Food and Drug Administration | 2020 |
[Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
Topics: Acarbose; Administration, Oral; Adverse Drug Reaction Reporting Systems; Benzamides; Biguanides; Data Mining; Databases, Pharmaceutical; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Pyrazines; Risk; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Triazoles | 2014 |
Meglitinide analogues in adolescent patients with HNF1A-MODY (MODY 3).
Topics: Adolescent; Benzamides; Child; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemia; Hypoglycemic Agents; Male | 2014 |
Treatment of young patients with HNF1A mutations (HNF1A-MODY).
Topics: Administration, Oral; Adolescent; Benzamides; Child; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemia; Hypoglycemic Agents; Insulins; Male; Mutation; Off-Label Use; Prospective Studies; Sulfonylurea Compounds | 2015 |